Ozena, also known as "fetid rhinitis", is a chronic disease of the nasal cavity characterized by atrophy of the mucous membrane and the formation of crusts, accompanied by an unpleasant odor, which causes significant discomfort to patients. This rare disease, usually affecting young and middle-aged people, can lead to respiratory problems and loss of smell. Ozena is caused by various factors, from infectious agents to hereditary predispositions, and requires a comprehensive approach to diagnosis and treatment. Despite its infrequent occurrence, ozena can negatively affect the quality of life of patients, provoking not only physiological but also psychoemotional disorders.
History of the disease and interesting historical facts
The history of ozena is full of mysteries and discoveries that go back to ancient times. The first mentions of the disease are found in medical texts of Ancient Egypt and Ancient Greece, where symptoms resembling this condition were described. In the 19th century, researchers such as the German physician Rudolf Virchow made a significant contribution to the understanding of the pathogenesis and clinical manifestations of ozena, conducting the first systematic study of the disease. Interestingly, for centuries ozena was associated with social and cultural prejudices: it was considered a disease of the “unclean” and “poor”. However, with the development of medicine and science, it became clear that this disease is not a consequence of an inappropriate lifestyle or personal hygiene, but has complex biological and genetic roots.
Epidemiology
Epidemiological data indicate that ozena is rare, its prevalence varies depending on the geographic location and population. According to various estimates, ozena occurs in 1-3 cases per 100,000 population. However, in some regions, especially in countries with poor health care and high prevalence of infectious diseases, the incidence rate can reach 10 per 100,000 population. It is important to note that the disease is more often observed in women, which may be due to the characteristics of the immune system and hormonal background. In recent decades, more than 50% cases of ozena have been registered in patients aged 20 to 40 years, which emphasizes the need for attention to the disease in this age range.
Genetic predisposition to this disease
Genetic studies have shown that ozena may have a hereditary component. Certain mutations in genes responsible for the normal function of the nasal epithelium may contribute to the development of the disease. In particular, abnormalities have been observed in genes associated with collagen metabolism and the structural integrity of the nasal mucosa. At the same time, genetic factors are not the only cause of ozena, but act in combination with predisposing factors such as infections and allergic reactions. However, the presence of cases of the disease in the family history may indicate an increased risk of development in subsequent generations, which requires additional research in the field of genetics and genomics.
Risk factors for the development of this disease
There are several risk factors that may contribute to the development of ozena. These include:
- Chronic upper respiratory tract infections leading to atrophic changes in the mucous membrane;
- Allergic rhinitis and sinusitis, which contribute to the disruption of the normal functioning of the nasal passages;
- Hereditary predisposition to diseases of the nasal cavity;
- Incorrect use of nasal sprays, especially those containing corticosteroids, which can cause tissue atrophy;
- Long-term exposure to chemicals and allergens such as tobacco smoke and industrial emissions.
These factors can combine, aggravating the clinical manifestations of the disease and complicating its diagnosis and treatment.
Diagnosis of this disease
Diagnosis of ozena includes several key stages:
- Main symptoms may include: difficulty breathing, persistent runny nose, bad smell from the nose, crusty formations;
- Laboratory tests, such as tests for infections, can help rule out other diseases;
- Radiological examinations (eg, sinus x-rays) allow us to assess the condition of bone structures and the presence of atrophy;
- Other types of diagnostics include endoscopic examination of the nasal cavity to assess the condition of the mucous membrane and identify possible complications;
- Differential diagnosis is necessary to exclude similar conditions such as rhinitis, sinusitis, and errors in patient management.
These methods allow a systematic approach to identifying the disease and establishing its further treatment.
Treatment
Treatment of ozena requires a comprehensive approach:
- General treatment includes lifestyle modification, improvement of hygiene conditions and treatment of concomitant diseases;
- Pharmacological treatment is based on the prescription of antibiotics in case of an infectious process, as well as hormonal agents to restore the normal function of the mucous membrane;
- Surgical treatment may be required in case of severe atrophy or irreversible changes in the nasal cavity;
- Other treatments may include physical therapy, inhalation therapy, and a special diet to help strengthen the immune system.
The effectiveness of treatment depends on the stage of the disease and the timeliness of seeking medical help.
List of medications used to treat this disease
The list of drugs used in the treatment of ozena may include:
- Antibiotics: amoxicillin, clarithromycin;
- Corticosteroids: fluticasone, budesonide;
- Immunomodulators: interferons;
- Saline solutions for nasal irrigation;
- Local anesthetics to reduce discomfort.
The drugs are selected individually depending on the clinical picture and characteristics of the patient.
Disease monitoring
Monitoring the condition of patients with ozena is important to assess the effectiveness of treatment and prevent complications. Control stages include:
- Regular examinations by an ENT doctor to assess the condition of the nasal mucosa;
- Application of instrumental diagnostic methods to assess the dynamics of the disease;
- The prognosis depends on the correct diagnosis and initiation of therapy; complications may include chronic infections and severe changes in the nasal cavity.
Regular monitoring of patients allows for timely adjustment of treatment measures.
Age-related features of the disease
Ozena may manifest itself differently in different age groups. In children, the disease is more often associated with upper respiratory tract infections, while in adolescents and young adults - with allergic factors and psychosomatic aspects. In older people, ozena may be aggravated by the presence of concomitant chronic diseases, which requires special attention in terms of diagnosis and treatment. It is important to take into account age-related changes, since each group has its own specifications and features of the course of the disease.
Questions and Answers
- What is ozena? Ozena is a chronic disease of the nose, characterized by atrophy of the mucous membrane and the formation of crusts with an unpleasant odor.
- What are the main symptoms of ozena? The main symptoms include difficulty breathing, persistent runny nose, crusty formations and a fetid odor from the nose.
- How is ozena diagnosed? Diagnosis includes examinations, laboratory tests, radiological examinations and endoscopy.
- What treatment is needed for ozena? Treatment may include medications, surgery, and other methods depending on the condition.
- What is the prognosis for the disease? The prognosis depends on the stage of the disease and the correctness of the treatment started; with timely therapy, complete recovery is possible.
